Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery
Tuberculosis (TB) remains a global healthcare crisis, with an estimated 5.8 million new cases and 1.5 million deaths in 2020. TB is caused by infection with the major human pathogen <i>Mycobacterium tuberculosis</i>, which is difficult to rapidly diagnose and treat. There is an urgent ne...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/9/11/2330 |